EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Robust HPV ‐16 Detection Workflow for Formalin‐Fixed Cancer Tissue and Its Application for Oral Squamous Cell Carcinoma

Shizuka Morodomi, Akiyuki Hirosue iD, Akhinur Rahman, Kyotaro Nohata, Misaki Matsuo iD, Omnia Reda, Samiul Alam Rajib, Haruki Saito, Hiroki Takeda, Ryoji Yoshida, Masafumi Nakamoto, Masatoshi Hirayama und 5 weitere

Cancer Medicine · 2025

DOI: 10.1002/cam4.70544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Shizuka Morodomi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Human papillomavirus 16, Papillomavirus Infections, Mouth Neoplasms, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Japan Science and Technology Corporation, MIRAI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Virus‐related cancers are malignancies caused by specific viruses, such as human papillomavirus (HPV), hepatitis B virus, and human T‐cell leukemia virus, contributing significantly to the global cancer burden through persistent infection and oncogenic transformation. The current study aimed to develop a robust HPV‐16 detection method for formalin‐fixed cancer specimens. Materials and Methods To prevent false negatives resulting from DNA fragmentation, a DNA quality check step was added. Additionally, this study used multiplex polymerase chain reaction (PCR) covering the entire HPV‐16 genome to mitigate effects caused by viral sequence variation. To prove this concept, we analyzed genomic DNA extracted from oropharyngeal cancer tissues known as HPV‐16‐positive. Subsequently, the protocol was tested on oral squamous cell carcinoma (OSCC) samples in our cohort. Given the wide variation in HPV‐16 positivity in previous studies, it remains elusive how frequently HPV‐16 is positive in OSCC.

Results

The results showed faint bands or smears in the multiplex PCR of 7 out of 112 cases. Droplet digital PCR confirmed variable positivity levels of HPV‐16, suggesting two scenarios of HPV‐16 positivity in cancer tissue: cancer cells derived from infected cells or only a portion being HPV‐16‐positive. Finally, we comprehensively analyzed the case and identified the integration of a deleted HPV‐16 genome into the intronic region of the host gene TMEM94 on chromosome 17. To the best of our knowledge, this is the first evidence showing the integration of HPV‐16 in OSCC cells and providing its complete viral sequence.

Conclusions

The established protocol should be applicable to various cancer tissues for analyzing the association with HPV‐16 infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Human papillomavirus 16Papillomavirus InfectionsMouth NeoplasmsSquamous Cell Carcinoma of Head and NeckCarcinoma, Squamous CellHumansMultiplex Polymerase Chain ReactionFormaldehydeDNA, ViralMaleWorkflowFemaleTissue FixationMiddle AgedAged

Stichwörter der Autor:innen

genetic diagnosisgenomic analysishead and neck cancerhuman papillomavirus (HPV)multiplex PCR

Substanzen

FormaldehydeDNA, Viral

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Division of Genomics and Transcriptomics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
  • Department of Infectious Disease Medicine, Tokyo Medical University Hospital, Tokyo, Japan.
  • University Côte d'Azur, INSERM, CNRS, Institute for Research on Cancer and Aging of Nice (IRCAN), Nice, France.
  • Department of Otolaryngology-Head and Neck Surgery, Kumamoto University Graduate School of Medicine, Kumamoto, Japan.

ORCID-Profile: Akiyuki Hirosue, Misaki Matsuo, Yorifumi Satou

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Japan Science and Technology Corporation, MIRAI

Zitieren

APA

Morodomi, S., Hirosue, A., Rahman, A., Nohata, K., Matsuo, M., Reda, O., Alam Rajib, S., Saito, H., Takeda, H., Yoshida, R., Nakamoto, M., Hirayama, M., Kawahara, K., Takatori, M., Orita, Y., Nakayama, H., & Satou, Y. (2025). Robust HPV ‐16 Detection Workflow for Formalin‐Fixed Cancer Tissue and Its Application for Oral Squamous Cell Carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.70544

Vancouver

Morodomi S, Hirosue A, Rahman A, Nohata K, Matsuo M, Reda O, et al. Robust HPV ‐16 Detection Workflow for Formalin‐Fixed Cancer Tissue and Its Application for Oral Squamous Cell Carcinoma. Cancer Medicine. 2025. doi:10.1002/cam4.70544

BibTeX
@article{Morodomi2025,
  author = {Morodomi, Shizuka and Hirosue, Akiyuki and Rahman, Akhinur and Nohata, Kyotaro and Matsuo, Misaki and Reda, Omnia and Alam Rajib, Samiul and Saito, Haruki and Takeda, Hiroki and Yoshida, Ryoji and Nakamoto, Masafumi and Hirayama, Masatoshi and Kawahara, Kenta and Takatori, Mitsuyoshi and Orita, Yorihisa and Nakayama, Hideki and Satou, Yorifumi},
  title = {Robust HPV ‐16 Detection Workflow for Formalin‐Fixed Cancer Tissue and Its Application for Oral Squamous Cell Carcinoma},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70544}
}
Kostenlos starten →